Summary
Natural language processing (NLP) and generative artificial intelligence (AI) are advancing at a rapid pace, as is their impact on life sciences and precision medicine. Listen to an informative session with IMO subject matter expert Xiaoyan Wang, PhD, FAMIA, who explores the complexities of AI tools, such as the advanced ChatGPT model, and their use within the healthcare industry.
Learn how NLP and gen AI:
Optimize clinical trials, streamlining design and improving recruitment
Accelerate hypothesis generation and literature analysis, supporting both new and repurposed drug development
Refine adverse drug reaction (ADR) analysis, improving drug safety
Featured speaker(s)
Xiaoyan Wang, PhD, FAMIA
Senior Vice President, Life Science Solutions
IMO
